Geoffrey Hamilton-Fairley is an experienced Chairman, NED and investment advisor with a track record of leading companies at different stages of development from start-ups through to sale and IPO. 

His entrepreneurial career started in 1982, founding a number of companies in Public Relations, Technology, Advertising and Music & Personality management backed by The Abingdon Management Company Limited, where he subsequently became sole owner having acquired Abingdon from its institutional shareholders. Abingdon had a number of quoted and unquoted investments including a Unit Trust, Foretronic (a technology company that introduced the magnetic data strip on the back of credit cards),  TVS (ITV franchise for the South of England), and a significant property portfolio in the UK and abroad. 

Returning to his medical roots, Geoffrey developed and guided Oncimmune, a company pioneering technologies to enable early cancer detection, from a Nottingham University start-up through to a successful IPO in May 2016, with total funds raised of £62m. During this period he co-authored numerous scientific and health economic publications. 

He now acts as an advisor to leading technology and healthcare funds, advising investment teams, specific due diligence projects, monitoring investments as a director and mentoring CEOs. 

Noel has 25 years of senior management experience as Director and Managing Director in high-tech manufacturing and software technology-based companies. He founded Genesis in 2010 to bring innovative supply chain technology solutions and best practice processes—proven in other sectors—to healthcare, with an aim to improve the quality and efficiency of patient care. Since then, Genesis has grown to become the Point of Care Traceability and Inventory Management solutions market leader in the UK. In 2017, Noel expanded the company and solution offerings to the United States, with a head office located in St. Petersburg, FL. The company is flourishing, with a 100% annual growth rate.

Mike has over 10 years of technology leadership and senior management experience in software-based companies. He is responsible for all aspects of product, technology and data analytics across the Genesis group. Having joined Genesis in 2012, Mike has collaborated closely with healthcare leaders to develop innovative technology solutions across the clinical supply chain, which has led to Genesis being the market leader in the UK. Mike has been responsible for establishing and expanding the R&D group, the professional services organization in the UK, and supporting commercial operations in the US.

Ian is responsible for all aspects of financial and commercial governance across the group. He is a member of The Institute of Chartered Accountants Ireland and has experience across a wide variety of industries, including information technology, building materials, construction, medical technology, bio sciences, manufacturing, pharmaceutical, software solutions and professional services. Prior to Genesis, Ian worked on the corporate development team of an FTSE 100 company as well as with Deloitte across both assurance and corporate finance practices.

Edward is an experienced private equity executive with 25 years of financial and principal investing experience. He has spent the last ten years focused on growth investments in the European mid-market. Prior to that, he was Regional Head of the UK and Northern European private equity business for Goldman Sachs’ Principal Investments Area, where he was responsible for over $1bn of investment in five portfolio companies in Europe and North America. Edward began his career with IBM in engineering and corporate development, working then with technologies that are prevalent in the healthcare industry today.

Cornel Riklin, Non-Executive Director, has over 20 years’ experience both as a company CEO and Managing Director and as a private equity investor. He is a founding partner of Caphaven LLP a private equity firm focussing on small company buy-outs and growth investments. Previously Cornel was CEO of two private equity owned businesses, European Directories and Findexa, and a partner at TPG Capital. Prior positions include Group Managing Director at Trinity Mirror plc, CEO of Borthwicks plc and five years as a strategy consultant at Bain & Company.  

Over the years Cornel has served on the board of a series of public and private companies and he holds an MBA from Harvard Business School. 

Rob joined Genesis in October 2021 and is responsible for all aspects of sales, marketing, operations and drives customer success in the UK and Ireland. He has a wide range of experience scaling businesses in Healthcare, Automotive and Defence, having held senior leadership roles in the UK, USA and Australia. Rob has an electronics background and has worked in SaaS, Product Design, Manufacturing and has been part of the Mergers and Acquisition team at three companies.

Noel has 25 years of senior management experience as Director and Managing Director in high-tech manufacturing and software technology-based companies. He founded Genesis in 2010 to bring innovative supply chain technology solutions and best practice processes—proven in other sectors—to healthcare, with an aim to improve the quality and efficiency of patient care. Since then, Genesis has grown to become the Point of Care Traceability and Inventory Management solutions market leader in the UK. In 2017, Noel expanded the company and solution offerings to the United States, with a head office located in St. Petersburg, FL. The company is flourishing, with a 100% annual growth rate.

Mike has over 10 years of technology leadership and senior management experience in software-based companies. He is responsible for all aspects of product, technology and data analytics across the Genesis group. Having joined Genesis in 2012, Mike has collaborated closely with healthcare leaders to develop innovative technology solutions across the clinical supply chain, which has led to Genesis being the market leader in the UK. Mike has been responsible for establishing and expanding the R&D group, the professional services organization in the UK, and supporting commercial operations in the US.

Ian is responsible for all aspects of financial and commercial governance across the group. He is a member of The Institute of Chartered Accountants Ireland and has experience across a wide variety of industries, including information technology, building materials, construction, medical technology, bio sciences, manufacturing, pharmaceutical, software solutions and professional services. Prior to Genesis, Ian worked on the corporate development team of an FTSE 100 company as well as with Deloitte across both assurance and corporate finance practices.